What hematology workup and management are indicated for a patient with an elevated iron panel, abdominal fullness, and anemia?

Elevated Iron Panel with Abdominal Fullness and Anemia: Hematology Workup and Management

This clinical presentation suggests hemochromatosis with possible iron overload complications, and you must immediately measure transferrin saturation and serum ferritin, followed by HFE genetic testing if transferrin saturation exceeds 45% or ferritin is elevated, then initiate therapeutic phlebotomy once iron overload is confirmed 1.

Initial Diagnostic Approach

The combination of elevated iron studies with anemia is paradoxical and requires systematic evaluation:

Critical Laboratory Tests to Order Now:

• Transferrin saturation - This is the key screening test; values >45% suggest hemochromatosis 2
• Serum ferritin - Elevated levels (>200-300 μg/L in women, >300 μg/L in men) indicate iron overload 1, 3
• Complete blood count - Confirm anemia severity and type
• Liver function tests - Assess hepatic involvement given abdominal fullness
• HFE genetic testing - If transferrin saturation elevated; look for C282Y homozygosity (>95% of hemochromatosis cases) 4

Important Diagnostic Nuance:

The presence of anemia with iron overload is unusual and demands investigation for alternative causes of anemia developing during treatment or concurrent conditions 1. An unexplained reduction in hemoglobin during iron overload workup should trigger a complete evaluation for gastrointestinal bleeding, malignancy, or other blood loss 1.

Imaging and Advanced Workup

If ferritin >1000 μg/L: Obtain liver elastography to identify advanced hepatic fibrosis 4. The abdominal fullness may represent hepatomegaly from iron deposition or early cirrhosis.

MRI of the liver provides non-invasive assessment of hepatic iron concentration and can confirm iron overload when diagnosis is uncertain 2, 3.

Management Algorithm

For Confirmed Hemochromatosis with Iron Overload:

Therapeutic phlebotomy is the first-line treatment and must be initiated immediately 1:

Induction Phase:

• Weekly or biweekly phlebotomy (450-500 mL blood removal)
• Check hemoglobin before each session:
  • If Hb <12 g/dL: reduce frequency
  • If Hb <11 g/dL: pause treatment 1
• Monitor ferritin after every 4 phlebotomies until it reaches 200 μg/L, then check every 1-2 sessions
• Target ferritin: 50 μg/L 1

Maintenance Phase (Lifelong):

• Frequency: 2-6 phlebotomies per year (individualized based on ferritin monitoring)
• Target ferritin: 50-100 μg/L 1
• Check ferritin and transferrin saturation every 6 months

Critical Caveat About the Anemia:

Do not delay phlebotomy solely because of mild anemia - the hemoglobin will typically normalize as iron stores are mobilized for erythropoiesis 1. However, if anemia is moderate-to-severe (Hb <10 g/dL), investigate other causes first:

• Gastrointestinal blood loss (especially given abdominal symptoms)
• Occult malignancy
• Concurrent nutritional deficiencies (B12, folate)
• Anemia of chronic disease 5

Alternative Treatment Options:

Erythrocytapheresis can be considered if available - it requires fewer procedures, causes less hemodynamic stress, and is cost-effective during induction 1. Target ferritin remains 50 μg/L for induction and 50-100 μg/L for maintenance.

Iron chelators (deferasirox, deferiprone, deferoxamine) are second-line and reserved only for patients who cannot tolerate phlebotomy or have severe anemia preventing blood removal 1, 4. These are particularly relevant in transfusion-dependent conditions with iron overload 6.

Mandatory Patient Counseling

• Avoid iron supplements, vitamin C supplements, and daily red meat consumption 1
• Avoid moderate-to-heavy alcohol - critical given potential liver involvement 1
• Avoid raw/undercooked seafood and contact of wounds with seawater (Vibrio vulnificus risk in iron overload) 1
• Proton pump inhibitors (if prescribed for other reasons) may reduce phlebotomy requirements 1

Prognosis and Monitoring

Life expectancy is normal when phlebotomy is initiated before cirrhosis or diabetes develops 1, 2. Morbidity and mortality are significantly reduced with early treatment. The abdominal fullness warrants urgent evaluation to determine if advanced fibrosis or cirrhosis is already present, as this fundamentally changes prognosis.

Common pitfall: Assuming that elevated iron studies always mean you should give more iron. In hemochromatosis, the opposite is true - you must remove iron. The key is distinguishing true iron overload (high ferritin + high transferrin saturation) from other causes of hyperferritinemia without iron overload (inflammation, alcohol, metabolic syndrome) 4.